Related Experiment Video
Updated: Aug 7, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Prostacyclin receptor-mediated activation of extracellular signal-regulated kinases 1 and 2
Kit Man Chu1, Kevin B S Chow, Yung H Wong
1Department of Pharmacology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong S.A.R, China.
Abstract:
The prostacyclin mimetic cicaprost increased phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in Chinese hamster ovary cells transiently expressing human (hIP-CHO) or mouse prostacyclin (mIP-CHO) receptors, but not in human neuroblastoma SK-N-SH cells or rat/mouse neuroblastoma-glioma NG108-15 cells which endogenously express IP receptors. Cicaprost stimulated ERK1/2 activity in hIP-CHO and mIP-CHO cells with EC50 values of 60 and 83 nM, respectively, and this response was significantly inhibited by protein kinase C inhibitors and agents which elevate cyclic AMP. A poor correlation was discovered between the level of ERK1/2 activity and the ability of agents to increase or decrease cyclic AMP production. The potent inhibitory effect of 3-isobutyl-1-methyl xanthine on cicaprost-stimulated phospho-ERK1/2 may be due to inhibition of phosphoinositide 3-kinase. Therefore, IP receptor-mediated activation of ERK1/2 in CHO cells occurs through a Gq/11/protein kinase C-dependent and a phosphoinoside 3-kinase-dependent process which is insensitive to IP receptor-generated cyclic AMP.
Insights
The prostacyclin mimetic cicaprost activates extracellular signal-regulated kinases 1 and 2 (ERK1/2) in cells with prostacyclin receptors. This activation involves protein kinase C and phosphoinositide 3-kinase, independent of cyclic AMP.
Area of Science:
- Cellular signaling pathways
- Molecular pharmacology
- Receptor-mediated signal transduction
Background:
- Prostacyclin receptors (IP receptors) mediate cellular responses to prostacyclin and its analogs.
- Extracellular signal-regulated kinases (ERK1/2) are key components of intracellular signaling cascades.
- Understanding IP receptor signaling is crucial for developing targeted therapeutics.
Purpose of the Study:
- To investigate the signaling mechanisms by which cicaprost activates ERK1/2 in cells expressing prostacyclin receptors.
- To determine the role of cyclic AMP (cAMP) and other signaling pathways in this activation.
- To compare signaling in cells with transiently expressed versus endogenously expressed IP receptors.
Main Methods:
- Transiently transfecting Chinese hamster ovary (CHO) cells with human (hIP-CHO) or mouse (mIP-CHO) prostacyclin receptors.
- Treating cells with cicaprost and measuring ERK1/2 phosphorylation.
- Utilizing protein kinase C inhibitors and agents that modulate cyclic AMP levels.
- Assessing the correlation between ERK1/2 activity and cyclic AMP production.
Main Results:
- Cicaprost increased ERK1/2 phosphorylation in hIP-CHO and mIP-CHO cells (EC50 values 60 and 83 nM, respectively).
- This activation was inhibited by protein kinase C inhibitors and agents that elevate cyclic AMP.
- A weak correlation was observed between ERK1/2 activity and cyclic AMP modulation.
- 3-isobutyl-1-methylxanthine inhibited cicaprost-stimulated phospho-ERK1/2, suggesting phosphoinositide 3-kinase involvement.
Conclusions:
- IP receptor-mediated ERK1/2 activation in CHO cells is dependent on Gq/11 and protein kinase C.
- Phosphoinositide 3-kinase plays a role in this signaling pathway.
- The activation of ERK1/2 by IP receptors in this context is insensitive to cyclic AMP levels generated by the receptor.
Related Concept Videos
Intracellular Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers
Amplifying Signals via Enzymatic Cascade
IP3/DAG Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

